New UK MHRA International Recognition Procedure set to streamline medicines applications post-Brexit

UK MHRA’s International Recognition Procedure (IRP) launch marks a key post-Brexit Health Technology Assessment (HTA) milestone, in an effort to speed up patient access to new medicines in the UK